[ad_1]
(MedPage Today) — The FDA ordered a clinical hold on a phase I study of the investigational obesity drug AMG 513, said developer Amgen.
Children’s Hospital Los Angeles has paused initiation of puberty blockers for transgender patients under age…
[ad_2]
Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/114175
Author :
Publish date : 2025-02-11 17:47:45
Copyright for syndicated content belongs to the linked Source.
FDA Pauses Obesity Drug Study; Diabetic Eye Therapy OK’d; ‘Misleading’ Super Bowl Ad
Related Posts
